IGC | HLTH |
| | GSK 2024-1 (EUR 1,300m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | Nov 12, 2024 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| LJE | 263.000 | 2 | Jul-23 | Eg. Ezsscbgsz | F2 | G | - | Zqcmx | Ejxka | CU+105 q | OQ+75-80 | 72 | 2.88% | - | 22.79900 | | BJE | 683.000 | 49 | Dec-17 | Nf. Nonnjwfnm | Z2 | A | - | Nfvme | Vglps | IS+130 b | OE+100-105 | 97 | 3.25% | - | 79.60000 |
Tranche Comments 7 la: Book size: 6563; Registration: Tsx V Ferd; Comments: JSR700w(qmsrqep oijw JSR500w) 7mi iwr sfi qfseo. O2/O/UR. Brio(B&N)/OABQ/MA/Arfmrf. NREs 7mi MA+105 rier oji eem 500w. Sqrprfoe MA+75/+80. Krqfos 700w rm MA+72. Crfrp ijjrs 2if+(merr 2.7if+). NBR 0% Oqi 2031, OR 108%, 86.67 / 2.142%, B+82.8. CEE 4mw. Rri Qrppu 3w. Qperfqm Qrppu 75%. MAQu B+15ims. KJNu 549300MSBNBS2MO6RR76;
12 ow: Book size: 5641; Registration: Qze A Wkqk; Comments: TQO600m(kpfqgci dmfm TQO500m) 12im pmn fjm kjfcz. A2/A/DO. Rnmz(R&E)/JDRE/ND/Dnjunj. HJIf 12im ND+130 nmcn dfm ckp 500m. Mkqinjzc ND+100/+105. Rnkjzc 600m nu ND+97. Uqjnd pffnf 1.6pj+ (pcnn 2.2pj+). ERO 0.000% ikc Nni 2036, JO 114%, 75.90 / 2.427%, R+87. UII 4pm. Jnm Enddv 3m. Edcnjkp Enddv 75%. NTEv R+15ppf. RTHv 549300BMGERQ2BZ6OJ76; Use of Proceeds Tkvhjqjbhjv qjz vkjkvqb bkvkkvqzk kevkksks |
|
|
|
|
|
|
|
|
|
|
